News

Photo of group of people standing in front of the U.S. Capitol Building

MIT Advocacy in Action at the AACR’s 2025 Hill Day

Koch Institute

May 29, 2025

MIT Koch Institute postdoc Meaghan McGeary traveled to Washington, DC to advocate for increased federal funding for cancer research as part of the annual American Association for Cancer Research (AACR) Hill Day. Joining other early-career scientists in a mission to make more than 50 congressional visits in a single day, she shared her experiences with policymakers, emphasizing the importance of stable research funding.  

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Showing 121–130 of 638 stories

Paula Hammond, 2024 Franklin Institute Awards Laureate

Franklin Institute

January 31, 2024

Congratulations to Paula Hammond, 2024 Franklin Institute Awards Laureate. Now marking the second century since its inception, the award has honored the most influential scientists, engineers, and inventors who have significantly advanced science and technology, including Nikola Tesla, Marie and Pierre Curie, Orville Wright, Thomas Edison, Albert Einstein, Jane Goodall, Stephen Hawking, and more recently, vaccine pioneers Kizzmekia Corbett, Drew Weissman, and Katalin Karikó. Hammond wins the medal in chemistry for her "innovative methods to create novel materials one molecular layer at a time, and for applying these materials to areas ranging from drug delivery to energy storage."

Nancy Hopkins to receive 2024 Public Welfare Medal 

MIT Koch Institute

January 24, 2024

Congratulations to Nancy Hopkins, who will receive the prestigious the National Academy of Sciences Public Welfare Medal for “her courageous leadership over three decades to create and ensure equal opportunity for women in science.”  The medal is the Academy’s most prestigious award, established in 1914 and presented annually to honor extraordinary use of science for the public good.

KI Investigators Take Initiative in Biotech Competition

MIT News

January 24, 2024

The MIT Faculty Founder Initiative has announced 12 finalists for the 2023-24 MIT-Royalty Pharma Prize Competition, among them KI faculty member Jessica Stark, Charles W. (1995) and Jennifer C. Johnson Clinical Investigator Joelle Straehla, and KI alums Ritu Raman and Theresa Raimondo. The competition aims to support female faculty entrepreneurs in biotechnology and provide them with resources to help take their ideas to commercialization. This spring, finalists will pitch their ideas to a committee of faculty, biotech founders, and venture capitalists, who will select a grand prize winner to receive $250,000 in discretionary funds, as well as breakthrough science award and runner-up award winners, who will each receive $100,000.

Programmable mRNA Takes a First Strand

Wired

January 22, 2024

Strand Therapeutics, co-founded by Darrell Irvine, Ron Weiss, and Weiss Lab alum Jacob Becraft, is targeting tumors for immunotherapy by "programming" mRNA to allow  it to turn on only in specific cell types, at specific times, and in specific amounts. The approach aims to avoid the systemic toxic side effects that often accompany cancer therapies when they are delivered to off-target tissue. This spring, Strand will enroll patients in a clinical trial of using its cancer-hunting mRNA therapy to treat solid tumors. The trial will be the first time a programmable mRNA therapy is tested in people.

A Family Tree for Blood Cells

STAT News

January 22, 2024

The Weissman Lab developed a method, dubbed "ReDeeM,"  for tracing the ancestry of human blood cells and mapping a cell’s lineage to its current behaviors. Researchers hope that, by monitoring changes in human blood cells in real time, ReDeeM could one day be used to predict disease risk years before symptoms show up. The lab is applying the technique, described in Nature, to learn more about  blood cancers, autoimmune disorders, and the origins of certain types of blood cells.

Better blood tests for cancer

MIT News

January 18, 2024

Liquid biopsy technologies leverage DNA shed by normal and tumor cells to diagnose and monitor disease from a simple blood draw, allowing earlier detection of cancer or recurrence and providing genetic information to guide treatment. New priming agents developed by the Love and Bhatia labs, with collaborator Viktor Adalsteinsson, improve the tests’ sensitivity, information yield, and patient applicability. This work was supported in part by the Koch Institute Frontier Research Program via the Casey and Family Foundation, the Bridge Project, and the Marble Center for Cancer Nanomedicine.

Langer wins 2023 Dr. Paul Janssen Award

New York Academy of Sciences

January 8, 2024

Congratulations to Robert Langer on winning the 2023 Dr. Paul Janssen Award for Biomedical Research in recognition of his groundbreaking work in designing novel drug delivery systems that can release medications continuously, precisely, and at controlled rates over extended periods. Established in 2004, the Dr. Paul Janssen Award has honored scientists who have made a transformational contribution toward the improvement of human health. Langer's award will be celebrated with a half-day virtual symposium, "Pioneering Novel Drug Delivery Systems," on February 8.

Inhalable sensors for early lung cancer detection

MIT News

January 5, 2024

Inhalable nanosensors from the Bhatia Lab could enable earlier lung cancer detection. When the nanosensors encounter cancer-linked proteins in the lungs, they release a signal that can be detected in the urine with a paper test strip. The diagnostic, described in Science Advances, could make lung cancer screening more accessible in places where CT scans, the current gold standard for detecting lung cancer, are not widely available. This study was funded in part by Johnson & Johnson Lung Cancer Initiative. Additional related work was supported by Marble Center for Cancer Nanomedicine and the Koch Institute Frontier Research Program via Upstage Lung Cancer.

Reducing Neuroinflammation via Nanoparticles

MIT News

December 15, 2023

Beyond cancer and vaccines, Langer’s lipid nanoparticles conquer new tissues. In a co-led study led with Li-Huei Tsai, a faculty member in the Department of Brain and Cognitive Sciences, researchers tested Langer's lipid nanoparticles in multiple mouse models and cultured human cells for their ability to deliver mRNA to the brain’s microglia immune cells and suppress expression of a protein linked to excessive inflammation in Alzheimer’s disease.

Angela Belcher delivers 2023 Dresselhaus Lecture

MIT News

December 13, 2023

Angela Belcher gave 2023 Mildred S. Dresselhaus Lecture at MIT last November, using her signature props to demonstrate the wide variety of concepts and projects made possible by the intersection of biology and nanotechnology. Belcher introduced her audiences to her work with the M13 bacteriophage, which has enabled her to make advances in building batteries, fuel cells, and solar cells to carbon sequestration and storage, environmental remediation, catalysis, and medical diagnostics and imaging—including for ovarian cancer. “Part of the secret of life and the meaning of life is helping other people enjoy the passage of time,” said Belcher. “I think that we can all do that by working to solve some of the biggest issues on the planet, including helping to diagnose and treat ovarian cancer early so people have more time to spend with their family.”